Six months later, another round of financing was completed, and Yuanxin technology completed the f round of over RMB 1.5 billion financing

Billion Europe health news on August 3, today, Yuanxin Technology Group announced that it had completed more than 1.5 billion yuan of round f financing. This round of financing is jointly invested by Sequoia Capital China fund, Springhill, B capital group, helved, orbited, UOB, e fund, ABI capital, Bank of China International, top strategy capital, CITIC Securities, Kunling capital, future startup, index capital, etc. index capital continues to act as its sole financial adviser. This is another financing completed by Yuanxin technology group after round D financing in June 2020 and round e financing in February 2021. It is reported that after this round of financing, Yuanxin Technology Group will further expand the out of hospital service network of patients and customize the post diagnosis course management system for patients with multiple diseases; Accelerate the construction of digital hospital network, build a patient service entrance, and provide patients with a full cycle diagnosis and treatment solution integrating inside and outside the hospital, online and offline; Further develop multi disease and multi form commercial health insurance products to meet users' multi-level medical and health security demands; Build it systems and data systems connecting patients, doctors, hospitals, pharmaceutical enterprises and insurance, and build digital infrastructure. Founded in 2015, Yuanxin Technology Group has always adhered to localized doctor-patient connection as the core, and gradually developed business matrices such as wonderful doctor, Yuanxin pharmacy, Yuanxin Huibao and Yuanxin medical technology, building a service bridge between doctors, pharmaceutical enterprises, insurance companies, hospitals and patients.